{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:43:08Z","timestamp":1791837788917,"version":"4.3.4"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Matrix Biology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.matbio.2020.03.005","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T20:33:46Z","timestamp":1584736426000},"page":"188-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Atrial fibrillation and cardiac fibrosis: A review on the potential of extracellular matrix proteins as biomarkers"],"prefix":"10.1016","volume":"91-92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9044-2475","authenticated-orcid":false,"given":"Alexander L.","family":"Reese-Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten S.","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper H.","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1984-1881","authenticated-orcid":false,"given":"Federica","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.matbio.2020.03.005_bib0001","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(06)68037-9","article-title":"Controversies in atrial fibrillation","volume":"367","author":"Nattel","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.matbio.2020.03.005_bib0002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.hrthm.2004.04.018","article-title":"Mortality as an endpoint in atrial fibrillation","volume":"1","author":"Beyerbach","year":"2004","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.matbio.2020.03.005_bib0003","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.matbio.2020.03.005_bib0004","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.matbio.2020.03.005_bib0005","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0006","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0007","doi-asserted-by":"crossref","first-page":"16016","DOI":"10.1038\/nrdp.2016.16","article-title":"Atrial fibrillation","volume":"2","author":"Lip","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.matbio.2020.03.005_bib0008","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham heart study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.matbio.2020.03.005_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.amjcard.2010.08.049","article-title":"A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the atherosclerosis risk in communities [ARIC] study)","volume":"107","author":"Chamberlain","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000102","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the charge-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.matbio.2020.03.005_bib0011","doi-asserted-by":"crossref","first-page":"H1223","DOI":"10.1152\/ajpheart.00079.2007","article-title":"Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure","volume":"293","author":"Akar","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cardiores.2006.06.016","article-title":"Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts","volume":"72","author":"Rucker-Martin","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0013","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000109495.02213.52","article-title":"Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation","volume":"109","author":"Xu","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.matbio.2020.03.005_bib0014","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cardiores.2004.08.020","article-title":"Structural and functional characterisation of cardiac fibroblasts","author":"Camelliti","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0008-6363(00)00030-4","article-title":"Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis","volume":"46","author":"MacKenna","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0016","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/hy0202.103268","article-title":"Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts","volume":"39","author":"Petrov","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.matbio.2020.03.005_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2015.12.031","article-title":"Origins of cardiac fibroblasts","author":"Moore-Morris","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0018","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s12265-012-9394-3","article-title":"The dynamic role of cardiac fibroblasts in development and disease","volume":"5","author":"Lajiness","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.matbio.2020.03.005_bib0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jcp.22322","article-title":"The origin of fibroblasts and mechanism of cardiac fibrosis","volume":"225","author":"Krenning","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0021","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-\u03b2-Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.matbio.2020.03.005_bib0022","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCRESAHA.118.313089","article-title":"Myofibroblast-specific TGF\u03b2 receptor ii signaling in the fibrotic response to cardiac myosin binding protein C-induced cardiomyopathy","volume":"123","author":"Meng","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0023","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cardiores.2007.07.013","article-title":"Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling","volume":"76","author":"Burstein","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0024","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s12265-012-9408-1","article-title":"The origin and arrhythmogenic potential of fibroblasts in cardiac disease","volume":"5","author":"Vasquez","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/cvr\/cvs290","article-title":"Similar arrhythmicity in hypertrophic and fibrotic cardiac cultures caused by distinct substrate-specific mechanisms","volume":"97","author":"Askar","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0026","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.patbio.2004.12.024","article-title":"The collagen superfamily: from the extracellular matrix to the cell membrane","volume":"53","author":"Ricard-Blum","year":"2005","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0027","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11886-000-0007-4","article-title":"The myocardial matrix and the development and progression of ventricular remodeling","volume":"2","author":"Sackner-Bernstein","year":"2000","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.matbio.2020.03.005_bib0028","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12265-013-9472-1","article-title":"Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction","volume":"6","author":"Zile","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0029","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.yjmcc.2010.12.019","article-title":"Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation","volume":"50","author":"Adam","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/path.1437","article-title":"Functional structure and composition of the extracellular matrix","volume":"200","author":"Bosman","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0031","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1161\/01.RES.0000224114.65109.4e","article-title":"Extracellular matrix remodeling and organization in developing and diseased aortic valves","volume":"98","author":"Hinton","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0032","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1002\/dvdy.20980","article-title":"ColVa1 and colxia1 are required for myocardial morphogenesis and heart valve development","volume":"235","author":"Lincoln","year":"2006","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.matbio.2020.03.005_bib0033","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1073\/pnas.94.5.1852","article-title":"Type iii collagen is crucial for collagen i fibrillogenesis and for normal cardiovascular development","volume":"94","author":"Liu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.matbio.2020.03.005_bib0034","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1242\/dev.01037","article-title":"Collagen iv is essential for basement membrane stability but dispensable for initiation of its assembly during early development","volume":"131","author":"Poschl","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.matbio.2020.03.005_bib0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0047-6374(88)90002-4","article-title":"Age-related changes in the proportion of types i and iii collagen","volume":"45","author":"Mays","year":"1988","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.matbio.2020.03.005_bib0036","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.RES.70.5.1006","article-title":"Isolation, characterization, and localization of cardiac collagen type VI. Associations with other extracellular matrix components","volume":"70","author":"Bashey","year":"1992","journal-title":"Circ. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0037","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0735-1097(89)90360-4","article-title":"Cardiac interstitium in health and disease: the fibrillar collagen network","volume":"13","author":"Weber","year":"1989","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0038","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.pharmtox.45.120403.095802","article-title":"THE cardiac FIBROBLAST: therapeutic target in myocardial remodeling and failure","volume":"45","author":"Brown","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0039","first-page":"2520","article-title":"Anti-angiogenic cues from vascular basement membrane collagen","volume":"60","author":"Colorado","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0040","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1172\/JCI24813","article-title":"Human\u202f\u03b11 type iv collagen NC1 domain exhibits distinct antiangiogenic activity mediated by\u202f\u03b11\u03b21 integrin","volume":"115","author":"Sudhakar","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2020.03.005_bib0041","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1248\/bpb.b17-00308","article-title":"New insights into the role of basement membrane-derived matricryptins in the heart","volume":"40","author":"Okada","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.matbio.2020.03.005_bib0042","first-page":"325","article-title":"Collagen remodeling after myocardial infarction in the rat heart","volume":"147","author":"Cleutjens","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0043","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1050-1738(98)00028-0","article-title":"Fibronectin-fibrin cross-linking: a regulator of cell behavior","volume":"8","author":"Corbett","year":"1998","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.matbio.2020.03.005_bib0044","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1247\/csf.24.19","article-title":"Expression of extracellular matrix components fibronectin and laminin in the human fetal heart","volume":"24","author":"Kim","year":"1999","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.matbio.2020.03.005_bib0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1006\/jmcc.2000.1119","article-title":"Outside-in signalling of fibronectin stimulates cardiomyocyte hypertrophy in cultured neonatal rat ventricular myocytes","volume":"32","author":"Ogawa","year":"2000","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0046","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1096\/fasebj.7.13.8405806","article-title":"Extracellular matrix 4: the elastic fiber","volume":"7","author":"Rosenbloom","year":"1993","journal-title":"FASEB J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0047","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0003-4975(03)01584-4","article-title":"Fibrillin and other matrix proteins in mitral valve prolapse syndrome","volume":"77","author":"Nasuti","year":"2004","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.matbio.2020.03.005_bib0048","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0945-053X(94)90186-4","article-title":"Fibromodulin distribution and association with collagen","volume":"14","author":"Hedlund","year":"1994","journal-title":"Matrix Biol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0049","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1025348417078","article-title":"Functions of lumican and fibromodulin: lessons from knockout mice","volume":"19","author":"Chakravarti","year":"2002","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0050","doi-asserted-by":"crossref","first-page":"11387","DOI":"10.1073\/pnas.162370099","article-title":"The gene expression fingerprint of human heart failure","volume":"99","author":"Tan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.matbio.2020.03.005_bib0051","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.hrthm.2007.03.034","article-title":"Increased expression of extracellular matrix proteins in rapid atrial pacing-induced atrial fibrillation","volume":"4","author":"Lin","year":"2007","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.matbio.2020.03.005_bib0052","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.2003.015347","article-title":"Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease","volume":"90","author":"Boldt","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.matbio.2020.03.005_bib0053","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ejhf.62","article-title":"Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the working group on myocardial function of the European society of cardiology","author":"Tarone","year":"2014","journal-title":"Eur. J. Heart Fail."},{"issue":"Suppl 1","key":"10.1016\/j.matbio.2020.03.005_bib0054","first-page":"107","article-title":"Myocardial fibrosis: role of angiotensin ii and aldosterone","volume":"88","author":"Weber","year":"1993","journal-title":"Basic Res. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.matbio.2020.03.005_bib0055","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.eupc.2004.07.003","article-title":"John camm a. atrial fibrillation and heart failure: natural history and pharmacological treatment","volume":"5","author":"Savelieva","year":"2004","journal-title":"Europace"},{"key":"10.1016\/j.matbio.2020.03.005_bib0056","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.RES.83.4.345","article-title":"\u2018Stress-responsive\u2019 mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium","author":"Sugden","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0057","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1006\/jmcc.1997.0524","article-title":"Molecular mechanisms of angiotensin ii in modulating cardiac function: intracardiac effects and signal transduction pathways mechanisms of angiotensin ii in modulating cardiac function: intracardiac effects and signal transduction","volume":"29","author":"Dostal","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0058","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2003.07.014","article-title":"Expression of angiotensin ii receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease","volume":"42","author":"Boldt","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0059","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0735-1097(00)00611-2","article-title":"Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation","volume":"35","author":"Goette","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0060","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0002-9440(10)63363-9","article-title":"Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death","volume":"165","author":"Xiao","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0061","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1006\/mgme.2000.3032","article-title":"Induction of cardiac fibrosis by transforming growth factor-beta(1)","volume":"71","author":"Lijnen","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.matbio.2020.03.005_bib0062","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0014-4827(02)00015-0","article-title":"TGF-\u03b21-mediated fibroblast-myofibroblast terminal differentiation - The role of Smad proteins","volume":"282","author":"Evans","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0063","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","article-title":"Fibrosis in heart disease: understanding the role of transforming growth factor-\u03b21 in cardiomyopathy, valvular disease and arrhythmia","volume":"118","author":"Khan","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.matbio.2020.03.005_bib0064","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.RES.86.5.571","article-title":"Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta1 transgene in the heart","volume":"86","author":"Nakajima","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0008-6363(00)00037-7","article-title":"Angiotensin ii directly increases transforming growth factor \u03b21 and osteopontin and indirectly affects collagen mRNA expression in the human heart","volume":"46","author":"Kupfahl","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0066","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.RES.0000150369.68826.2f","article-title":"Transforming growth factor \u03b2 receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II","volume":"95","author":"Chen","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0067","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","article-title":"Potential therapeutic targets for cardiac fibrosis: tGF\u03b2, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation","volume":"106","author":"Leask","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0068","doi-asserted-by":"crossref","first-page":"H1719","DOI":"10.1152\/ajpheart.00130.2013","article-title":"Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts","volume":"304","author":"Zhao","year":"2013","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0069","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yexcr.2016.10.022","article-title":"PDGF-A and PDGF-B induces cardiac fibrosis in transgenic mice","volume":"349","author":"Gallini","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0070","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0955-0674(02)00361-7","article-title":"Matricellular proteins: extracellular modulators of cell function","volume":"14","author":"Bornstein","year":"2002","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0071","doi-asserted-by":"crossref","DOI":"10.1007\/s12079-009-0069-z","article-title":"Matricellular proteins: an overview","volume":"3","author":"Bornstein","year":"2009","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.matbio.2020.03.005_bib0072","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cardiores.2004.06.006","article-title":"Matricellular proteins in the heart: possible role during stress and remodeling","volume":"64","author":"Schellings","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0073","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cytogfr.2008.01.002","article-title":"Regulation and function of connective tissue growth factor\/CCN2 in tissue repair, scarring and fibrosis","volume":"19","author":"Shi-Wen","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.matbio.2020.03.005_bib0074","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.yjmcc.2003.12.004","article-title":"Connective tissue growth factor - A novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats","volume":"36","author":"Ahmed","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0075","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1253\/circj.CJ-10-0892","article-title":"Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes","volume":"75","author":"Ko","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0076","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2009.08.064","article-title":"Rac1-Induced connective tissue growth factor regulates connexin 43 and N-Cadherin expression in atrial fibrillation","volume":"55","author":"Adam","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0077","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.matbio.2014.02.001","article-title":"Invoking the power of thrombospondins: regulation of thrombospondins expression","volume":"37","author":"Stenina-Adognravi","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0078","article-title":"Thrombospondin-1: multiple paths to inflammation","author":"Gutierrez","year":"2011","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.matbio.2020.03.005_bib0079","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.bbagen.2014.01.013","article-title":"Thrombospondin-2 and extracellular matrix assembly","volume":"1840","author":"Calabro","year":"2014","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.matbio.2020.03.005_bib0080","first-page":"5699","article-title":"Increased expression of the TSP-1\/TGF-\u03b2\/MMP-9 axis in atrial fibrillation related to rheumatic heart disease","volume":"11","author":"Yang","year":"2018","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.matbio.2020.03.005_bib0081","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1536\/ihj.18-246","article-title":"Thrombospondin-2 as a potential risk factor in a general population","volume":"60","author":"Morikawa","year":"2019","journal-title":"Int. Heart J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0082","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0945-053X(00)00104-9","article-title":"Thrombospondin 2, a matricellular protein with diverse functions","volume":"19","author":"Bornstein","year":"2000","journal-title":"Matrix Biol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0083","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.matbio.2020.03.005_bib0084","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cvr\/cvx016","article-title":"Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure","volume":"113","author":"Li","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCRESAHA.107.160408","article-title":"Osteopontin expression is required for myofibroblast differentiation","volume":"102","author":"Lenga","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0086","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.HYP.0000128621.68160.dd","article-title":"Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy","volume":"43","author":"Matsui","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.matbio.2020.03.005_bib0087","first-page":"26","article-title":"Relationship between serum osteopontin level and atrial fibrillation recurrence in patients undergoing cryoballoon catheter ablation","volume":"45","author":"G\u00fcnes","year":"2017","journal-title":"Turk Kardiyol Dern Ars"},{"key":"10.1016\/j.matbio.2020.03.005_bib0088","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jacc.2017.08.014","article-title":"Tenascin-C in cardiac hypertrophy and fibrosis: friend or foe?","volume":"70","author":"Park","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0089","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ejhf.464","article-title":"Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy","volume":"18","author":"Yokokawa","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.matbio.2020.03.005_bib0090","article-title":"Serum tenascin-C levels in atrium predict atrial structural remodeling processes in patients with atrial fibrillation","author":"Shiomi","year":"2019","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0091","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10741-011-9266-y","article-title":"Tissue inhibitor of metalloproteinases (TIMPs) in heart failure","volume":"17","author":"Moore","year":"2012","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.matbio.2020.03.005_bib0092","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0008-6363(00)00003-1","article-title":"Feldman a M. interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling","volume":"46","author":"Li","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0093","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.CIR.98.17.1699","article-title":"Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds","volume":"98","author":"Mann","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.matbio.2020.03.005_bib0094","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/01.CIR.102.16.1944","article-title":"A matrix metalloproteinase induction\/activation system exists in the human left ventricular myocardium and is upregulated in heart failure","volume":"102","author":"Spinale","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.matbio.2020.03.005_bib0095","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.matbio.2020.03.005_bib0096","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cardiores.2005.09.004","article-title":"Integrins, membrane-type matrix metalloproteinases and ADAMs: potential implications for cardiac remodeling","author":"Manso","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0097","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.semcdb.2007.06.008","article-title":"Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis","author":"Barbolina","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0098","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1074\/jbc.270.19.11555","article-title":"Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase\/type iv collagenase: high affinity binding to native type i collagen but not native type iv collagen","volume":"270","author":"Steffensen","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.matbio.2020.03.005_bib0099","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024753","article-title":"MMP mediated degradation of type vi collagen is highly associated with liver fibrosis - Identification and validation of a novel biochemical marker assay","author":"Veidal","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.matbio.2020.03.005_bib0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cardiores.2005.04.016","article-title":"Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation","volume":"67","author":"Ann\u00e9","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0101","doi-asserted-by":"crossref","first-page":"H1847","DOI":"10.1152\/ajpheart.00434.2006","article-title":"Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction","volume":"292","author":"Bergman","year":"2006","journal-title":"AJP Heart Circ. Physiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0102","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2003.08.060","article-title":"Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation","volume":"43","author":"Nakano","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0103","doi-asserted-by":"crossref","first-page":"H1656","DOI":"10.1152\/ajpheart.00141.2011","article-title":"Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling","volume":"301","author":"Zavadzkas","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0104","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","article-title":"Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-\u03b2 and promotes tumor invasion and angiogenesis","volume":"14","author":"Yu","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.matbio.2020.03.005_bib0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.matbio.2020.03.005_bib0106","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS BLED) to assest 1-Year risk of major bleeding in patients with atrial fibrillation","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163621","article-title":"A simple, non-invasive score to predict paroxysmal atrial fibrillation","volume":"11","author":"Kallenberger","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.matbio.2020.03.005_bib0108","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0735-1097(02)02969-8","article-title":"Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome","volume":"41","author":"James","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0109","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/01.CIR.0000084543.79097.34","article-title":"Cardiac troponin i is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure","volume":"108","author":"Horwich","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.matbio.2020.03.005_bib0110","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","article-title":"Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a rely substudy","volume":"125","author":"Hijazi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.matbio.2020.03.005_bib0111","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/eurheartj\/ehy815","article-title":"Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation","volume":"40","author":"Chua","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0112","first-page":"1","article-title":"N-terminal pro-brain natriuretic peptide and atrial fibrillation","volume":"9","author":"Thejus","year":"2009","journal-title":"Indian Pacing Electrophysiol. J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0113","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2017.07.018","article-title":"Natriuretic propeptides as markers of atrial fibrillation burden and recurrence (from the amio-cat trial)","volume":"120","author":"Darkner","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0114","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","author":"Daniels","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijcard.2014.11.046","article-title":"NT-proBNP in \u2018low risk\u2019 patients with atrial fibrillation","volume":"179","author":"Kornej","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0116","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.873265","article-title":"N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the cardiovascular health study","volume":"120","author":"Patton","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.matbio.2020.03.005_bib0117","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1136\/heartjnl-2013-304724","article-title":"N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the multi-ethnic study of atherosclerosis: the effects of age, sex and ethnicity","volume":"99","author":"Patton","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.matbio.2020.03.005_bib0118","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jacc.2010.05.049","article-title":"Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation","volume":"56","author":"Smith","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0119","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehi350","article-title":"Inflammation in the genesis and perpetuation of atrial fibrillation","author":"Engelmann","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0120","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","author":"Hu","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0121","doi-asserted-by":"crossref","first-page":"461","DOI":"10.14503\/THIJ-13-3466","article-title":"Inflammation and C-Reactive protein in atrial fibrillation: cause or effect? the pathogenesis of atrial fibrillation","volume":"41","author":"Galea","year":"2014","journal-title":"Texas Heart Inst. J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0122","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00380-004-0800-x","article-title":"C-Reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation","volume":"20","author":"Watanabe","year":"2005","journal-title":"Heart Vessels"},{"key":"10.1016\/j.matbio.2020.03.005_bib0123","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/00365510802676848","article-title":"Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion","volume":"69","author":"Henningsen","year":"2009","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.matbio.2020.03.005_bib0124","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/14017430802653676","article-title":"Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation","volume":"43","author":"Henningsen","year":"2009","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0125","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.genm.2012.09.001","article-title":"Inflammatory biomarkers as risk factors for future atrial fibrillation. an eleven-year follow-up of 6315 men and women: the Troms\u00f8 study","volume":"9","author":"Nyrnes","year":"2012","journal-title":"Gend. Med."},{"key":"10.1016\/j.matbio.2020.03.005_bib0126","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.amjcard.2007.04.014","article-title":"Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction","volume":"100","author":"Aronson","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0127","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00011-009-0146-z","article-title":"Plasma YKL-40 is elevated in patients with recurrent atrial fibrillation after catheter ablation","volume":"59","author":"Henningsen","year":"2010","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0128","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/europace\/eup103","article-title":"Plasma YKL-40, a new biomarker for atrial fibrillation?","volume":"11","author":"Henningsen","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.matbio.2020.03.005_bib0129","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/hrt.2010.217281","article-title":"Very high coronary calcium score unmasks obstructive coronary artery disease in patients with normal SPECT MPI","volume":"97","author":"Ghadri","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.matbio.2020.03.005_bib0130","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/STROKEAHA.111.678078","article-title":"Coronary artery calcification is an independent stroke predictor in the general population","volume":"44","author":"Hermann","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.matbio.2020.03.005_bib0131","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.amjcard.2014.09.005","article-title":"Coronary artery calcium and risk of atrial fibrillation (from the multi-ethnic study of atherosclerosis)","volume":"114","author":"O'Neal","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0132","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ahj.2005.04.031","article-title":"Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the strong heart study (SHS)","volume":"151","author":"Kizer","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0133","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2003.12.018","article-title":"Mitral annular calcification is a predictor for incident atrial fibrillation","volume":"173","author":"Fox","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.matbio.2020.03.005_bib0134","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/europace\/euu265","article-title":"Mitral annular calcification and incident atrial fibrillation in the multi-ethnic study of atherosclerosis","volume":"17","author":"O'Neal","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.matbio.2020.03.005_bib0135","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/eurheartj\/eht024","article-title":"Biomarkers in atrial fibrillation: a clinical review","author":"Hijazi","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.matbio.2020.03.005_bib0136","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/ijcp.12304","article-title":"Biomarkers in atrial fibrillation: an overview","author":"V\u00edlchez","year":"2014","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.matbio.2020.03.005_bib0137","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cvr\/cvx055","article-title":"Increased collagen within the transverse tubules in human heart failure","volume":"113","author":"Crossman","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0138","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10741-009-9143-0","article-title":"Extracellular matrix fibrotic markers in heart failure","volume":"15","author":"Zannad","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.matbio.2020.03.005_bib0139","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.CIR.98.6.535","article-title":"Abnormalities of the extracellular degradation of collagen type I in essential hypertension","volume":"98","author":"Laviades","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.matbio.2020.03.005_bib0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.HYP.0000024573.17293.23","article-title":"TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension","volume":"40","author":"Lindsay","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.matbio.2020.03.005_bib0141","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2010.04.034","article-title":"The prognostic value of circulating markers of collagen turnover after acute myocardial infarction","volume":"150","author":"Manhenke","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0142","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00392-012-0440-6","article-title":"Procollagen propeptides: serum markers for atrial fibrosis?","volume":"101","author":"Neuberger","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0143","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/0300060513488514","article-title":"Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation","volume":"42","author":"Li","year":"2014","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0059052","article-title":"Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the atherosclerosis risk in communities study","volume":"8","author":"Huxley","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.matbio.2020.03.005_bib0145","first-page":"742","article-title":"Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation","volume":"45","author":"Chen","year":"2008"},{"key":"10.1016\/j.matbio.2020.03.005_bib0146","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.amjcard.2005.08.073","article-title":"Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation","volume":"97","author":"Mukherjee","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0147","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/1354750X.2013.789084","article-title":"Quantification of \u2018end products\u2019 of tissue destruction in inflammation may reflect convergence of cytokine and signaling pathways-implications for modern clinical chemistry","author":"Karsdal","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.matbio.2020.03.005_bib0148","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.clinbiochem.2011.08.1135","article-title":"Protein fingerprints - Relying on and understanding the information of serological protein measurements","volume":"44","author":"Karsdal","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.matbio.2020.03.005_bib0149","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1535-6108(03)00133-8","article-title":"Physiological levels of Tumstatin, a fragment of collagen iv \u03b13 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via \u03b1V\u03b23 integrin","volume":"3","author":"Hamano","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.matbio.2020.03.005_bib0150","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbrc.2006.12.231","article-title":"Identification of novel short peptides derived from the\u202f\u03b14,\u202f\u03b15, and\u202f\u03b16 fibrils of type iv collagen with anti-angiogenic properties","volume":"354","author":"Karagiannis","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.matbio.2020.03.005_bib0151","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1586\/14789450.2016.1134327","article-title":"Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers","author":"Genovese","year":"2016","journal-title":"Expert Rev. Proteomics."},{"key":"10.1016\/j.matbio.2020.03.005_bib0152","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre profile study","volume":"3","author":"Jenkins","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.matbio.2020.03.005_bib0153","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-016-0440-6","article-title":"High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the eclipse study","volume":"17","author":"Sand","year":"2016","journal-title":"Respir. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0154","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chest.2016.08.1440","article-title":"Systemic biomarkers of collagen and elastin turnover are associated with clinically relevant outcomes in COPD","volume":"151","author":"Stolz","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.matbio.2020.03.005_bib0155","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.clinbiochem.2016.09.003","article-title":"Characterization of serological neo-epitope biomarkers reflecting collagen remodeling in clinically stable chronic obstructive pulmonary disease","volume":"49","author":"Sand","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.matbio.2020.03.005_bib0156","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-017-0509-x","article-title":"Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD","volume":"18","author":"Bihlet","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.matbio.2020.03.005_bib0157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175898","article-title":"Non-invasive quantification of collagen turnover in renal transplant recipients","volume":"12","author":"Stribos","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.matbio.2020.03.005_bib0158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175200","article-title":"Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease","volume":"12","author":"Fenton","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.matbio.2020.03.005_bib0159","doi-asserted-by":"crossref","first-page":"17328","DOI":"10.1038\/s41598-017-17470-3","article-title":"Urinary endotrophin predicts disease progression in patients with chronic kidney disease","volume":"7","author":"Rasmussen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.matbio.2020.03.005_bib0160","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ndt\/gfv301","article-title":"Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IGA nephropathy","volume":"31","author":"Genovese","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.matbio.2020.03.005_bib0161","doi-asserted-by":"crossref","DOI":"10.2337\/dc17-2392","article-title":"Higher collagen VI formation is associated with all-cause mortality in patients with type 2 diabetes and microalbuminuria","author":"Rasmussen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.matbio.2020.03.005_bib0162","first-page":"174","article-title":"A MMP derived versican neo-epitope is elevated in plasma from patients with atherosclerotic heart disease","volume":"6","author":"Barascuk","year":"2013","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.matbio.2020.03.005_bib0163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-10-140","article-title":"Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker","volume":"10","author":"Vassiliadis","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.matbio.2020.03.005_bib0164","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/2047487318758750","article-title":"Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: an iPOWER substudy","volume":"25","author":"Nielsen","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.matbio.2020.03.005_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-23458-4","article-title":"Matrix metalloproteinase mediated type I collagen degradation is an independent predictor of increased risk of acute myocardial infarction in postmenopausal women","volume":"8","author":"Bertelsen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.matbio.2020.03.005_bib0166","first-page":"1","article-title":"A biomarker of collagen type i degradation is associated with cardiovascular events and mortality in patients with atherosclerosis","author":"Holm Nielsen","year":"2018","journal-title":"J. Intern. Med."}],"container-title":["Matrix Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X20300263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X20300263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:00:53Z","timestamp":1760554853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0945053X20300263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":166,"alternative-id":["S0945053X20300263"],"URL":"https:\/\/doi.org\/10.1016\/j.matbio.2020.03.005","relation":{},"ISSN":["0945-053X"],"issn-type":[{"value":"0945-053X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation and cardiac fibrosis: A review on the potential of extracellular matrix proteins as biomarkers","name":"articletitle","label":"Article Title"},{"value":"Matrix Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.matbio.2020.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}